Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Change in Cash (2019 - 2025)

Benitec Biopharma (BNTC) has disclosed Change in Cash for 7 consecutive years, with $46.9 million as the latest value for Q2 2025.

  • Quarterly Change in Cash rose 27.62% to $46.9 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $46.9 million through Jun 2025, down 3.12% year-over-year, with the annual reading at $46.9 million for FY2025, 3.12% down from the prior year.
  • Change in Cash hit $46.9 million in Q2 2025 for Benitec Biopharma, up from -$17.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $46.9 million in Q2 2025 to a low of -$17.0 million in Q4 2024.
  • Historically, Change in Cash has averaged $4.9 million across 5 years, with a median of -$3.7 million in 2022.
  • Biggest YoY gain for Change in Cash was 1002.4% in 2024; the steepest drop was 209.27% in 2024.
  • Year by year, Change in Cash stood at -$3.4 million in 2021, then plummeted by 76.46% to -$6.0 million in 2022, then rose by 8.46% to -$5.5 million in 2023, then crashed by 209.27% to -$17.0 million in 2024, then soared by 376.44% to $46.9 million in 2025.
  • Business Quant data shows Change in Cash for BNTC at $46.9 million in Q2 2025, -$17.0 million in Q4 2024, and $17.0 million in Q3 2024.